INSMED INCORPORATED
-
Open
39.67
-
Previous Close
39.44
-
Volume (Avg)
930.82k (942.89k)
-
Day's Range
38.90-40.39
-
52Wk Range
12.09-42.71
-
Market Cap.
4.02B
-
Dividend Rate ( Yield)
-
-
Beta
2.34
-
Shares Outstanding
101.87M
-
P/E Ratio (EPS)
-
Top Stories
-
Insmed Inc
CNBC 6 days agoThere is no recent news for this security. There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC ...
-
Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
Associated Press -
Zacks: Analysts Expect Insmed Incorporated (NASDAQ:INSM) Will Announce Quarterly Sales of $40.71 Million
modernreaders.com -
Lobe Sciences Announces Management Changes and New Director
Stockhouse -
Insmed Incorporated
Reuters 3/18/2020Jan 4 (Reuters) - Insmed Inc <INSM.O>::INSMED INITIATES FRONTLINE CLINICAL TRIAL PROGRAM FOR ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH MAC LUNG DISEASE.INSMED INC ...
-
SVB Leerink Raises Insmed (NASDAQ:INSM) Price Target to $55.00
modernreaders.com -
Insmed, Inc. Common Stock (INSM)
Nasdaq -
Arena Pharmaceuticals Announces R&D Leadership Transition
Business Wire -
Inducted in 2017
Drexel University -
Symbol Lookup from Yahoo Finance
Yahoo Finance -
Helix Acquisition Corp
Bloomberg -
Insmed Inc.
Barron's -
Lobe Sciences Ltd.: Lobe Sciences Announces Management Changes and New Director
Finanznachrichten -
Insmed, Inc. Common Stock (INSM)
Nasdaq -
Insmed Inc. Overweight
Business Insider 12/16/2020Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Summary: Insmed Inc. Overweight Analyst Opinions for Insmed Inc.More Latest Analyst Opinions 05:15 AM 12/16/2020 05:15:56 ...
-
Insmed Inc. Buy
Business Insider -
Insmed Inc
U.S. News & World Report -
Insmed Inc.
Barron's